top of page
  • Glenn Hearson

Idiopathic Pulmonary Fibrosis Job Exposure Study (IPF JES)

Updated: Sep 5, 2022

IPF JES is a research study that aims to discover if workplaces are a cause of idiopathic pulmonary fibrosis (IPF). Dr Gauri Saini leading for us in Nottingham along with Lucy Howard.


What is the purpose of this trial?

Idiopathic pulmonary fibrosis (also called IPF) is a disease that causes scarring ofthe lungs. The scarring damages the air sacs that allow oxygen to be transferred to the blood and transported to vital organs. IPF is a serious illness that causes cough, shortness of breath, and fatigue.

We don’t know what causes IPF but it is becoming more common in England, Scotland and Wales where it affects over 4000 people each year. People who get IPF are usually older than 40; the disease is more common in men and in parts of the country with a history of heavy industry.

This study will help to find out how much IPF can be attributed to workplace environments in England, Scotland and Wales. This will help us to better understand the causes of IPF, make sure people get the right treatment and compensation they are entitled to, and ensure that the controls at work are right so that we protect workers and prevent disease in the future.

This study is now fully completed

bottom of page